Mr. David Lee:

We are seeing a noticeable uptick in the questionnaires we are receiving from our clients as part of their third-party risk management asking us to satisfy them that we are treating their data appropriately from a GenAI perspective. Those questions have been informed by the principles of the Act. Our clients are doing that in the context of establishing their own AI exposure registers.